These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8775258)

  • 61. High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications.
    Sakata K; Nagakura H; Oouchi A; Someya M; Nakata K; Shido M; Koito K; Sagae S; Kudo R; Hareyama M
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1369-76. PubMed ID: 12459359
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Investigation of rectal and bladder complications after RALS therapy for carcinoma of the uterine cervix].
    Teshima T; Chatani M; Hata K; Inoue T; Suzuki T
    Gan No Rinsho; 1984 Nov; 30(14):1793-800. PubMed ID: 6513032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
    Yeh SA; Wan Leung S; Wang CJ; Chen HC
    Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlations of dose and time-dose-fractionation factors (TDF) with treatment results and side effects in cancer of the uterine cervix.
    Yudelev M; Kuten A; Tatcher M; Rubinov R; Karmeli R; Cohen Y; Robinson E
    Gynecol Oncol; 1986 Mar; 23(3):310-5. PubMed ID: 3957116
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
    Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
    Logsdon MD; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bladder and intestinal injuries following radiation therapy of carcinoma of the uterine cervix.
    Johnsson JE
    Acta Radiol Ther Phys Biol; 1976 Dec; 15(6):541-9. PubMed ID: 829591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-dose rate intracavitary therapy for carcinoma of the uterine cervix: II. Risk factors for rectal complication.
    Teshima T; Chatani M; Hata K; Inoue T
    Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):281-6. PubMed ID: 3338950
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A prospective randomized study concerning to the point A dose in high-dose rate intracavitary radiation therapy for carcinoma of the uterine cervix.
    Chatani M; Teshima T; Inoue T
    Strahlenther Onkol; 1991 Dec; 167(12):701-7. PubMed ID: 1763406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Late bladder complications following radiotherapy of carcinoma of the uterine cervix].
    Li A; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):741-3. PubMed ID: 8728921
    [TBL] [Abstract][Full Text] [Related]  

  • 72. De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Kim KH; Kim S; Kim GE; Koom WS; Kim SW; Nam EJ; Suh CO; Kim YB
    Gynecol Oncol; 2015 Dec; 139(3):439-46. PubMed ID: 26456139
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
    Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY
    Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis.
    Lee KK; Lee JY; Nam JM; Kim CB; Park KR
    Brachytherapy; 2015; 14(4):449-57. PubMed ID: 25906951
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Results of radiation therapy with the conformation technic in carcinoma of the uterine cervix].
    Morita K; Watanabe M; Fuwa N
    Gan No Rinsho; 1986 Dec; 32(15):1959-69. PubMed ID: 3100840
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dose determination in bladder and rectum during intracavitary irradiation of cervix carcinoma.
    Mak AC; van 't Riet A; Ypma AF; Veen RE; van Slooten FH
    Radiother Oncol; 1987 Oct; 10(2):97-100. PubMed ID: 3321201
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Radiotherapy for cervical cancer patients with high-dose rate brachytherapy: application of shielded colpostats].
    Ito H; Kutuki S; Nishiguchi I; Kuribayashi T; Nakayama T; Takemasa K; Uematsu M; Ando Y; Ogawa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jan; 54(1):46-54. PubMed ID: 8121770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.